Literature DB >> 1856809

Antinuclear antibody profile in juvenile rheumatoid arthritis.

W Szer1, H Sierakowska, I S Szer.   

Abstract

Immunoblot positive sera from children with juvenile rheumatoid arthritis detected from 1 to greater than or equal to 10 proteins in HeLa nuclear sonicates. Thirty percent of the sera reacted with histone H1. Antibodies to at least 1 of 6 most frequently detected nonhistone proteins were present in 85% of the sera. Using immunopurified antibodies to each of the 6 common antigens, we found that 4 of them were associated with mitotic chromosomes. Most sera detected at least 1 of these 4 nonhistone chromosomal proteins. Fifteen percent of the sera immunoprecipitated ribonucleoproteins; some exhibited a novel specificity, precipitating mature transcripts of RNA polymerase III. When present, antibodies to a 45 kDa protein occur only in sera from children without iritis and not in those with active iritis. Overall, the antibody profiles were highly individual and did not appear to correlate with disease subtype or activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856809

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 2.  Antinuclear antibodies and juvenile chronic arthritis (JCA): search for a specific autoantibody associated with JCA.

Authors:  T R Southwood; P N Malleson
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis.

Authors:  H Sierakowska; K R Williams; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

4.  Solution NMR structure of the C-terminal domain of the human protein DEK.

Authors:  Matthew Devany; N Prasad Kotharu; Hiroshi Matsuo
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

5.  B-cell pathology in juvenile idiopathic arthritis.

Authors:  V Wiegering; H J Girschick; H Morbach
Journal:  Arthritis       Date:  2010-12-02

6.  High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.

Authors:  Nirit Mor-Vaknin; Miguel Rivas; Maureen Legendre; Smriti Mohan; Ye Yuanfan; Theresa Mau; Anne Johnson; Bin Huang; Lili Zhao; Yukiko Kimura; Steven J Spalding; Paula W Morris; Beth S Gottlieb; Karen Onel; Judyann C Olson; Barbara S Edelheit; Michael Shishov; Lawrence K Jung; Elaine A Cassidy; Sampath Prahalad; Murray H Passo; Timothy Beukelman; Jay Mehta; Edward H Giannini; Barbara S Adams; Daniel J Lovell; David M Markovitz
Journal:  Arthritis Rheumatol       Date:  2018-02-22       Impact factor: 10.995

7.  DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.

Authors:  Nirit Mor-Vaknin; Anjan Saha; Maureen Legendre; Carmelo Carmona-Rivera; M Asif Amin; Bradley J Rabquer; Marta J Gonzales-Hernandez; Julie Jorns; Smriti Mohan; Srilakshmi Yalavarthi; Dave A Pai; Kristine Angevine; Shelley J Almburg; Jason S Knight; Barbara S Adams; Alisa E Koch; David A Fox; David R Engelke; Mariana J Kaplan; David M Markovitz
Journal:  Nat Commun       Date:  2017-02-06       Impact factor: 14.919

Review 8.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04

9.  DEK binding to class II MHC Y-box sequences is gene- and allele-specific.

Authors:  Barbara S Adams; Hyuk C Cha; Joanne Cleary; Tan Haiying; Hongling Wang; Kajal Sitwala; David M Markovitz
Journal:  Arthritis Res Ther       Date:  2003-05-23       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.